If you work in bioscience at Cortex or are considering it, your work amenities just expanded.

Cortex has announced a partnership providing access to core research facilities located at SLU and WashU for companies based at CET.

14 core facilities will provide startup and growing companies at CET@CIC with access to equipment and expertise to scale high-growth bioscience ventures.

“We’re thrilled to deepen our partnerships with our founding partners WashU and SLU by streamlining access to core research facilities that are essential for emerging companies,” said Dennis Lower, president and CEO of Cortex.

“It represents a tremendous added value for companies choosing to make CIC@CET home. Startup companies have limited financial resources; having access to sophisticated analytic equipment within a few blocks of their labs preserves cash and can lessen time to market.”

The partnership marks an expansion of available research-related facilities including cores for mass spectrometry, NMR, flow cytometry, comparative medicine, genomics, protein purification, high throughput screening, microscopy, cell/hybridoma development, GMP production and proteomics. They’ve also standardized and streamlined the process for obtaining contracts to use the equipment. 

CET has been the launchpad for companies like Exegy, Cardialen, and Stereotaxis and is currently the home of growing ventures including C2N Diagnostics, Orion Genomics, BacterioScan and EndoStim.

“WashU has invested in numerous core facilities, ensuring that our researchers have access to the latest equipment and technologies,” stated Jenny Lodge, Vice Chancellor for Research at Washington University.

“To offer access to these same facilities and provide the needed technical support to startup companies in CIC@CET is a valuable extension of our research mission at WashU.”

“Access to sophisticated facilities and talented SLU faculty certainly can help a start-up to leverage its resources in ways that advance its core technologies more efficiently than would be possible if it were doing the work alone,” says Raymond Tait, PhD, Vice President for Research at SLU.